Highlights Biotalys NV

Equities

BTLS

BE0974386188

Market Closed - Euronext Bruxelles Other stock markets 11:35:10 2024-05-16 am EDT			5-day change	1st Jan Change
3.02 ^EUR	0.00%		-0.66%	-35.33%

May. 02	Biotalys Starts Field Trials for Second Biofungicide	CI
Apr. 30	Biotalys Announces Board and Committee Changes	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Biotalys Starts Field Trials for Second Biofungicide	May. 02	CI
Biotalys, Novonesis Sign Deal to Advance Biofungicide Candidate Development	Mar. 18	MT
Biotalys and Novonesis Announces Manufacturing and Commercialization Partnership for EVOCA NG	Mar. 18	CI
Biotalys NV Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 22	CI
Biotalys Inks Plant Pathology Research Agreements in Europe, US	Feb. 08	MT
Biotalys Announces Results of Independent Field Trials in the U.S	Dec. 19	CI
Biotalys NV Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-23	CI
Biotalys, Syngenta Crop Protection Partner to Develop Sustainable Agriculture Technology	23-04-24	MT
Syngenta Crop Protection and Biotalys Announces Collaboration to Develop New Biocontrol Solutions	23-04-24	CI
Biotalys announces Chief Financial Officer succession plan	23-03-14	GL
Biotalys announces Chief Financial Officer succession plan	23-03-14	AQ
Biotalys NV Announces Chief Financial Officer Changes	23-03-14	CI
Biotalys Reports Full-Year 2022 Financial Results and Business Highlights	23-02-28	GL
Biotalys Reports Full-Year 2022 Financial Results and Business Highlights	23-02-28	AQ
Biotalys NV Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-28	CI
Biotalys Targets 2026 Release of Biofungicide After Hitting Production Efficiency Milestone	23-01-26	MT
Biotalys announces participation at investor and industry events for the remainder of 2022	22-11-07	GL
Biotalys announces participation at investor and industry events for the remainder of 2022	22-11-07	AQ
Biotalys Nv and Novozymes A/S Announces Successful Evoca™ Feasibility Study	22-10-24	CI
Biotalys announces participation at investor and industry events for the upcoming months	22-09-13	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Biotalys NV

Equities

BTLS

BE0974386188

Highlights

Filters